PhiSkin has raised $17.7m in a series B round led by Legend Capital and will use the funding to expand its range of cosmetic treatment centres across China.

The UC Davis spinout has collected $20m in series B capital from Bow Capital, a VC fund affiliated with the university.

A host of corporates, some of which had not been disclosed previously, have put in a total of $25m of funding into Grabit.

Novartis and GlaxoSmithKline have returned to back a series B round that also attracted Singapore state-backed Vertex Ventures and university venturing fund Cambridge Innovation Capital.

Novartis and GlaxoSmithKline have returned to back a series B round that also attracted Singapore state-backed Vertex Ventures and university venturing fund Cambridge Innovation Capital.

Innogy is among a group of investors that has provided $10m in series B capital.

The co-working spaces provider has collected capital from a consortium featuring Wecash.